Published in Am J Trop Med Hyg on September 01, 1980
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin. J Clin Microbiol (1984) 1.47
Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin. Infect Immun (1982) 1.44
Properties of synthetically produced Escherichia coli heat-stable enterotoxin. Infect Immun (1983) 1.20
Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit. Infect Immun (1983) 1.19
Enterotoxigenic Escherichia coli in a population of infants with diarrhea in Chile. J Clin Microbiol (1985) 1.19
Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03
Molecular homogeneity of heat-stable enterotoxins produced by bovine enterotoxigenic Escherichia coli. Infect Immun (1984) 0.88
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect Immun (1974) 12.51
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Meningococcal disease. N Engl J Med (2001) 8.50
A phage-typing scheme for Salmonella enteritidis. Epidemiol Infect (1987) 7.42
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med (1982) 6.62
International increase in Salmonella enteritidis: a new pandemic? Epidemiol Infect (1990) 5.94
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03
An investigation of traveller's diarrhoea. Lancet (1970) 4.99
Interventions for the control of diarrhoeal diseases among young children: improving water supplies and excreta disposal facilities. Bull World Health Organ (1985) 4.89
Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA (1995) 4.70
Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med (1978) 4.56
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Salmonella enteritidis phage type 4 infection: association with hen's eggs. Lancet (1988) 4.31
Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Epidemic in cattle and humans of Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec (1994) 3.91
Infectious disease surveillance: a crumbling foundation. Science (1994) 3.89
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Case-control study of infections with Salmonella enteritidis phage type 4 in England. BMJ (1989) 3.79
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70
Prospective study of diarrheal illnesses in northeastern Brazil: patterns of disease, nutritional impact, etiologies, and risk factors. J Infect Dis (1983) 3.65
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli. Nature (1978) 3.60
Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain. J Hyg (Lond) (1986) 3.60
Ciprofloxacin and typhoid fever. Lancet (1992) 3.59
The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol (1996) 3.54
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest (1981) 3.50
Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg (1999) 3.25
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Application of pulsed-field gel electrophoresis to an international outbreak of Salmonella agona. Emerg Infect Dis (1996) 3.22
Treatment of multiresistant typhoid fever. Lancet (1991) 3.18
Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J Clin Microbiol (1977) 3.11
Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06
Cytopathogenic mechanisms of Entamoeba histolytica. J Exp Med (1980) 3.06
Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology (1990) 3.04
Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child (1990) 3.04
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry. Am J Epidemiol (1997) 2.86
Outbreak of Salmonella napoli infection caused by contaminated chocolate bars. Lancet (1983) 2.82
Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
Serological analysis of chicken flocks for antibodies to Salmonella enteritidis. Vet Rec (1990) 2.79
Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA (1977) 2.71
Spread of multiresistant strains of Salmonella typhimurium phage types 204 and 193 in Britain. Br Med J (1978) 2.71
Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann Intern Med (1994) 2.66
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
A new technique for sampling duodenal contents: demonstration of upper small-bowel pathogens. Am J Trop Med Hyg (1970) 2.63
Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans. Infect Immun (1982) 2.62
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis (1998) 2.59
Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet (1996) 2.58
Changing trends in US mesothelioma incidence. Occup Environ Med (2004) 2.56
The most abundant small cytoplasmic RNA of Saccharomyces cerevisiae has an important function required for normal cell growth. Mol Cell Biol (1989) 2.55
Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. J Infect Dis (1980) 2.52
Salmonella enteritidis phage type 4 from the contents of intact eggs: a study involving naturally infected hens. Epidemiol Infect (1989) 2.52
New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans. Infect Immun (1982) 2.52
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47
Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation. J Infect Dis (1972) 2.46
Subdivision of Salmonella enteritidis PT 4 by pulsed-field gel electrophoresis: potential for epidemiological surveillance. FEMS Microbiol Lett (1994) 2.44
Neonatal meningitis caused by Citrobacter koseri. J Clin Pathol (1973) 2.43
Blood pressure survey in pregnancy. Clin Sci (1969) 2.42
Poultry meat as a source of human salmonellosis in England and Wales. Epidemiological overview. Epidemiol Infect (1988) 2.38
Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet (1976) 2.31
Glucose utilization in vivo by human pulmonary neoplasms. Cancer (1987) 2.29
Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol (1991) 2.28
Investigation of outbreaks of salmonella in hospitals. Br Med J (Clin Res Ed) (1983) 2.27
A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet (1994) 2.26
Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils. J Infect Dis (1981) 2.26
Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells. J Clin Invest (1973) 2.25
The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med (1997) 2.24
Diarrhoea and catch-up growth. Lancet (1990) 2.24
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Subdivision of Salmonella enteritidis phage types by plasmid profile typing. Epidemiol Infect (1989) 2.15
Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J Clin Microbiol (1998) 2.14
The emergence of ciprofloxacin resistance in Salmonella typhimurium. J Antimicrob Chemother (1990) 2.13
The possession of three novel coli surface antigens by enterotoxigenic Escherichia coli strains positive for the putative colonization factor PCF8775. J Gen Microbiol (1985) 2.12
Acquisition of a drug resistance plasmid converts Salmonella enteritidis phage type 4 to phage type 24. Epidemiol Infect (1989) 2.11
Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol (1989) 2.08
The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand. J Infect Dis (1986) 2.06
A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev (1994) 2.04
Asbestos exposure--quantitative assessment of risk. Am Rev Respir Dis (1986) 2.04
Emerging infectious diseases: public health issues for the 21st century. Science (1999) 2.03
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med (1990) 2.03
Persistent diarrhea signals a critical period of increased diarrhea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis (2000) 2.01
Food poisoning: notifications, laboratory reports, and outbreaks--where do the statistics come from and what do they mean? Commun Dis Rep CDR Rev (1996) 2.01
Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00
HEp-2 adhesion and the expression of a 94 kDa outer-membrane protein by strains of Escherichia coli belonging to enteropathogenic serogroups. J Gen Microbiol (1988) 1.99
Enteroaggregative Escherichia coli. Emerg Infect Dis (1998) 1.98
Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut (1993) 1.98
Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist (1997) 1.96
Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest (2000) 1.96
The role of Escherichia coli in gastroenteritis. Clin Gastroenterol (1979) 1.94
Infectious diseases in competitive sports. JAMA (1994) 1.92